## PART 1 of 5 — Concept Review Questions (Not a Test
Bank, Not a Substitute for Publisher Materials)
### Pharmacotherapeutics for Advanced Practice Nurse
Prescribers, 6th Edition — Woo & Wright
**Textbook:** *Pharmacotherapeutics for Advanced
Practice Nurse Prescribers*, 6th Edition
**Authors:** Teri Moser Woo, Marylou V. Robinson
**Publisher:** F.A. Davis Company
**Target Audience:** Doctor of Nursing Practice (DNP)
students — prescribing foundation
**Certification Alignment:** AACN DNP Essentials (Essential
VIII: Advanced Nursing Practice); ANCC/AANP APRN
certification pharmacotherapeutics domains
**Part Coverage:** Part 1: Foundations of Prescribing (Units I–II, Chapters 1–10)
**Questions:** 1–70
---
## CHAPTER 1: THE ROLE OF THE NURSE PRACTITIONER AS PRESCRIBER — Questions 1–10
**1. A DNP student is analyzing the regulatory framework for APRN prescribing. Which body has
primary authority to establish and enforce prescriptive regulations at the state level?**
A. The Drug Enforcement Administration (DEA)
B. The state board of nursing, in conjunction with the state legislature and board of pharmacy
C. The American Nurses Credentialing Center (ANCC)
D. The Centers for Medicare & Medicaid Services (CMS)
,**Correct Answer: B**
**Rationale:** Prescriptive authority is granted and regulated primarily at the state level
through the board of nursing, working with the legislature and board of pharmacy. Option A
regulates controlled substances at the federal level but does not establish APRN prescriptive scope.
Option C is a certifying body that validates competency but does not grant prescriptive authority.
Option D administers federal reimbursement programs. Recognizing the layered regulatory structure
is foundational for safe prescribing.
---
**2. Which dimension best describes the "holistic" advantage of APRN prescribing compared to
other prescriber types?**
A. APRNs prescribe more medications per visit
B. APRNs assess the patient's psychological, social, and environmental context alongside the
biomedical problem
C. APRNs avoid pharmacological therapy whenever possible
D. APRNs prescribe only generic medications
**Correct Answer: B**
**Rationale:** APRN prescribers are trained to assess the whole patient — including
psychosocial, cultural, and environmental factors that influence medication selection, adherence,
and outcomes. Option A is not a clinical advantage. Option C is inaccurate. Option D is inaccurate.
Holistic assessment is a hallmark of advanced practice nursing.
---
**3. Which statement best describes the role of clinical judgment in prescribing?**
A. Clinical judgment in prescribing is limited to matching a diagnosis to a drug
B. Clinical judgment in prescribing integrates evidence, patient-specific factors, cost, safety, and
patient preference into drug selection and monitoring
,C. Clinical judgment in prescribing is unrelated to patient preferences
D. Clinical judgment in prescribing is limited to adverse-effect monitoring
**Correct Answer: B**
**Rationale:** Clinical judgment in prescribing integrates evidence-based guidelines, patient-
specific data (comorbidities, renal/hepatic function, age, pregnancy status), cost considerations,
safety, and patient preference. Option A is too narrow. Option C is incorrect. Option D is too narrow.
Clinical judgment is the core of safe prescribing.
---
**4. A DNP-prepared APRN is developing a formulary for a clinic. Which consideration is most
important in drug selection?**
A. Physician preference only
B. Matching the drug's mechanism to the patient's pathophysiology, with attention to efficacy, safety,
cost, and patient-specific factors
C. Insurance coverage only
D. Drug advertising
**Correct Answer: B**
**Rationale:** Drug selection requires matching mechanism of action to the patient's
pathophysiology while considering efficacy, safety, cost, and patient-specific factors. Option A is not
patient-centered. Option C is a factor but not the most important. Option D is not a clinical basis.
Understanding rational drug selection is essential.
---
**5. Which factor most directly determines whether an APRN prescriber needs a DEA number?**
A. Whether the APRN prescribes any medications at all
, B. Whether the APRN prescribes or administers controlled substances
C. Whether the APRN practices in a hospital
D. Whether the APRN is certified
**Correct Answer: B**
**Rationale:** A DEA number is required only for prescribing or administering controlled
substances. Option A is too broad. Option C is incorrect — practice setting does not determine DEA
necessity. Option D is incorrect — certification does not substitute for DEA registration.
Understanding DEA registration is essential for controlled-substance prescribing.
---
**6. Which statement best describes the role of collaborative practice agreements in states with
reduced or restricted APRN practice authority?**
A. They are optional in all states
B. They outline the scope and terms of APRN-physician collaboration in states where supervision or
delegation is required
C. They grant prescriptive authority independently of the state board of nursing
D. They are required only for hospital-based practice
**Correct Answer: B**
**Rationale:** Collaborative practice agreements are required in many reduced- and restricted-
practice states to define the terms of APRN-physician collaboration. Option A is incorrect — they are
required in many states. Option C is incorrect — prescriptive authority comes from the state board.
Option D is incorrect — the requirement is state-based, not setting-based. Understanding state
practice authority is essential.
---
**7. Which statement best describes the standard of care for APRN prescribing?**
Bank, Not a Substitute for Publisher Materials)
### Pharmacotherapeutics for Advanced Practice Nurse
Prescribers, 6th Edition — Woo & Wright
**Textbook:** *Pharmacotherapeutics for Advanced
Practice Nurse Prescribers*, 6th Edition
**Authors:** Teri Moser Woo, Marylou V. Robinson
**Publisher:** F.A. Davis Company
**Target Audience:** Doctor of Nursing Practice (DNP)
students — prescribing foundation
**Certification Alignment:** AACN DNP Essentials (Essential
VIII: Advanced Nursing Practice); ANCC/AANP APRN
certification pharmacotherapeutics domains
**Part Coverage:** Part 1: Foundations of Prescribing (Units I–II, Chapters 1–10)
**Questions:** 1–70
---
## CHAPTER 1: THE ROLE OF THE NURSE PRACTITIONER AS PRESCRIBER — Questions 1–10
**1. A DNP student is analyzing the regulatory framework for APRN prescribing. Which body has
primary authority to establish and enforce prescriptive regulations at the state level?**
A. The Drug Enforcement Administration (DEA)
B. The state board of nursing, in conjunction with the state legislature and board of pharmacy
C. The American Nurses Credentialing Center (ANCC)
D. The Centers for Medicare & Medicaid Services (CMS)
,**Correct Answer: B**
**Rationale:** Prescriptive authority is granted and regulated primarily at the state level
through the board of nursing, working with the legislature and board of pharmacy. Option A
regulates controlled substances at the federal level but does not establish APRN prescriptive scope.
Option C is a certifying body that validates competency but does not grant prescriptive authority.
Option D administers federal reimbursement programs. Recognizing the layered regulatory structure
is foundational for safe prescribing.
---
**2. Which dimension best describes the "holistic" advantage of APRN prescribing compared to
other prescriber types?**
A. APRNs prescribe more medications per visit
B. APRNs assess the patient's psychological, social, and environmental context alongside the
biomedical problem
C. APRNs avoid pharmacological therapy whenever possible
D. APRNs prescribe only generic medications
**Correct Answer: B**
**Rationale:** APRN prescribers are trained to assess the whole patient — including
psychosocial, cultural, and environmental factors that influence medication selection, adherence,
and outcomes. Option A is not a clinical advantage. Option C is inaccurate. Option D is inaccurate.
Holistic assessment is a hallmark of advanced practice nursing.
---
**3. Which statement best describes the role of clinical judgment in prescribing?**
A. Clinical judgment in prescribing is limited to matching a diagnosis to a drug
B. Clinical judgment in prescribing integrates evidence, patient-specific factors, cost, safety, and
patient preference into drug selection and monitoring
,C. Clinical judgment in prescribing is unrelated to patient preferences
D. Clinical judgment in prescribing is limited to adverse-effect monitoring
**Correct Answer: B**
**Rationale:** Clinical judgment in prescribing integrates evidence-based guidelines, patient-
specific data (comorbidities, renal/hepatic function, age, pregnancy status), cost considerations,
safety, and patient preference. Option A is too narrow. Option C is incorrect. Option D is too narrow.
Clinical judgment is the core of safe prescribing.
---
**4. A DNP-prepared APRN is developing a formulary for a clinic. Which consideration is most
important in drug selection?**
A. Physician preference only
B. Matching the drug's mechanism to the patient's pathophysiology, with attention to efficacy, safety,
cost, and patient-specific factors
C. Insurance coverage only
D. Drug advertising
**Correct Answer: B**
**Rationale:** Drug selection requires matching mechanism of action to the patient's
pathophysiology while considering efficacy, safety, cost, and patient-specific factors. Option A is not
patient-centered. Option C is a factor but not the most important. Option D is not a clinical basis.
Understanding rational drug selection is essential.
---
**5. Which factor most directly determines whether an APRN prescriber needs a DEA number?**
A. Whether the APRN prescribes any medications at all
, B. Whether the APRN prescribes or administers controlled substances
C. Whether the APRN practices in a hospital
D. Whether the APRN is certified
**Correct Answer: B**
**Rationale:** A DEA number is required only for prescribing or administering controlled
substances. Option A is too broad. Option C is incorrect — practice setting does not determine DEA
necessity. Option D is incorrect — certification does not substitute for DEA registration.
Understanding DEA registration is essential for controlled-substance prescribing.
---
**6. Which statement best describes the role of collaborative practice agreements in states with
reduced or restricted APRN practice authority?**
A. They are optional in all states
B. They outline the scope and terms of APRN-physician collaboration in states where supervision or
delegation is required
C. They grant prescriptive authority independently of the state board of nursing
D. They are required only for hospital-based practice
**Correct Answer: B**
**Rationale:** Collaborative practice agreements are required in many reduced- and restricted-
practice states to define the terms of APRN-physician collaboration. Option A is incorrect — they are
required in many states. Option C is incorrect — prescriptive authority comes from the state board.
Option D is incorrect — the requirement is state-based, not setting-based. Understanding state
practice authority is essential.
---
**7. Which statement best describes the standard of care for APRN prescribing?**
